美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
39602 A II 2024/03/08 BIOPHORE INDIA PHARMACEUTICALS PVT LTD RISDIPLAM
39522 A II 2024/03/07 FUJIAN GENOHOPE BIOTECH LTD SEMAGLUTIDE
38843 A II 2024/03/07 GRANULES INDIA LTD RIFAXIMIN PH. EUR
39606 A IV 2024/03/07 INTAS PHARMACEUTICALS LTD SODIUM CHOLESTERYL SULFATE FOR PHARMACEUTICAL USE
39653 A II 2024/03/06 ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD FOLIC ACID
39688 A III 2024/03/06 AMPACET CORP 4400534-K ORANGE 534
39724 A III 2024/03/06 AMPACET CORP 111343-NT BLUE WHITE PE MB
39418 A II 2024/03/06 SPI PHARMA INC MAGNESIUM HYDROXIDE USP BARCROFT™ 5100 CG POWDER
39512 A II 2024/03/06 FDC LTD BRINZOLAMIDE USP
39257 A II 2024/03/06 HENAN LIHUA PHARMACEUTICAL CO LTD BETAMETHASONE SODIUM PHOSPHATE
39259 A II 2024/03/06 HENAN LIHUA PHARMACEUTICAL CO LTD DEXAMETHASONE SODIUM PHOSPHATE
39558 A III 2024/03/06 CHONGQING ZHENGCHUAN YONGCHENG PHARMACEUTICAL MATERIAL CO LTD BOROSILICATE GLASS BARRELS FOR PEN-INJECTORS
39088 A II 2024/03/05 DEVA HOLDING AS POMALIDOMIDE
39568 A II 2024/03/05 SUPRIYA LIFESCIENCE LTD ALLOPURINOL USP
39578 A II 2024/03/05 JIANGSU LIANHUAN PHARMACEUTICAL CO LTD PHENTOLAMINE MESYLATE
39539 A II 2024/03/04 EMCURE PHARMACEUTICALS LTD HYDROXYZINE HYDROCHLORIDE USP
39551 A III 2024/03/04 TOTALENERGIES PETROCHEMICALS AND REFINING TOTALENERGIES POLYPROPYLENE ACESO PPM R021 S01
39604 A II 2024/03/04 LINHAI TIANYU PHARMACEUTICAL CO LTD APIXABAN
39495 A II 2024/03/03 HUISHENG BIOPHARMACEUTICAL CO LTD SEMAGLUTIDE
39583 A II 2024/03/02 LEE PHARMA LTD ELETROMBOPAG OLAMINE

数据库说明:

当前数据更新日期:2024年6月(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2024 DrugFuture->U.S. FDA Drug Master Files